Brookfield, in its proposal, has offered to buy the company at A$4.60 per share, representing a 6.5% premium to Insignia Financial's last closing price on Tuesday. The Brookfield offer has triggered a ...

Insignia on Wednesday said that Brookfield made a non-binding proposal of 4.60 Australian dollars, or US$2.88, a share. That is the same value as the proposal made last month by C ...

A Rockville immunotherapy company struck an $8 million deal to take back ownership of the drug candidates it’s been licensing ...